SYNERGY™ XD H7493941832450Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08714729981237), received between Jun 28, 2021 and May 15, 2026 — classified as 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Break” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break5
- Difficult to Advance1
- Failure to Deflate1
- Inflation Problem1
- Material Rupture1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- Cardiac Arrest1
- Foreign Body In Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 15, 2026Break; Difficult to Advance
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERY DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. AFTER THE LESION WAS PRE-DILATED WITH GOOD EXPANSION, A NON-BOSTON SCIENTIFIC (NON-BSC) GUIDE CATHETER AND A NON-BSC GUIDEWIRE WERE USED. A 4.50 X 32 MM SYNERGY? XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. THE PHYSICIAN ENCOUNTERED RESISTANCE DURING ADVANCEMENT IN THE PROXIMAL PORTION OF THE GUIDE JUST PAST THE TOUHY VALVE BUT WAS EVENTUALLY ABLE TO ADVANCE THE SYSTEM. THE STENT WAS SUCCESSFULLY DEPLOYED. DURING WITHDRAWAL OF THE DELIVERY SYSTEM FROM THE GUIDE, THE SHAFT BROKE IN HALF. THE ENTIRE DEVICE WAS REMOVED FROM THE PATIENT WITHOUT ISSUE, AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25186857 ↗MalfunctionJan 20, 2026Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 75% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED CORONARY ARTERY. A 4.50 X 32MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR TREATMENT. HOWEVER, DURING INFLATION, THE BALLOON RUPTURED. THE DEVICE WAS REMOVED SUCCESSFULLY WITH NO FRAGMENTS LEFT, AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED. IT WAS FURTHER REPORTED THAT THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY. DURING INFLATION, CONTRAST FROM THE STENT BALLOON WAS COMING OUT FROM THE SHAFT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24125310 ↗InjuryAug 1, 2025Break; Failure to Deflate; Break; Failure to Deflate
IT WAS REPORTED THAT DEFLATION FAILURE AND SHAFT BREAK OCCURRED RESULTING IN CARDIAC ARREST, ADDITIONAL INTERVENTION AND AN UNRETRIEVED DEVICE FRAGMENT. THE TARGET LESION WAS LOCATED IN THE CIRCUMFLEX ARTERY. A STENT WAS INITIALLY PLACED IN THE CIRCUMFLEX ARTERY, FOLLOWED BY A 4.50 X 32MM SYNERGY XD DRUG-ELUTING STENT PLACED IN THE CIRCUMFLEX ARTERY EXTENDING TO THE LEFT MAIN OSTIUM. AFTER DEPLOYMENT, THE BALLOON FAILED TO DEFLATE. MULTIPLE UNSUCCESSFUL ATTEMPTS WERE MADE TO DEFLATE THE BALLOON WITH THE INFLATION DEVICE. A HORNET 14 GUIDEWIRE WAS THEN USED TO ATTEMPT TO PUNCTURE THE BALLOON. ADDITIONALLY, THE BACK END OF THE BALLOON WAS CUT OFF IN AN ATTEMPT TO RELEASE THE PRESSURE. WHEN THE PHYSICIAN TRIED TO RETRACT THE BALLOON, THE BALLOON SHAFT BROKE, LEAVING THE BALLOON STUCK IN THE LEFT MAIN/CIRCUMFLEX ARTERY. THE PATIENT BECAME UNSTABLE AND EXPERIENCED CARDIAC ARREST AND A MINIMALLY INVASIVE, TEMPORARY HEART PUMP WAS PLACED. A SECOND PHYSICIAN SCRUBBED IN AND WAS ABLE TO ADVANCE A NON-BOSTON SCIENTIFIC GUIDEWIRE AND A MICROCATHETER PAST THE BALLOON TO THE DISTAL CIRCUMFLEX. THEN, A 2.0 BALLOON WAS ADVANCED AND WAS ABLE TO RESTORE FLOW. THE PHYSICIAN USED PROGRESSIVELY BIGGER
Patient problems: Cardiac Arrest; Foreign Body In Patient
MAUDE report 22690330 ↗InjuryMay 2, 2025Break; Inflation Problem; Break; Inflation Problem
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED REQUIRING ADDITIONAL INTERVENTION. A 4.50 X 32 MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. DURING THE PROCEDURE, THE STENT BALLOON FAILED TO INFLATE. WHILE ATTEMPTING TO REMOVE THE DEVICE, THE PHYSICIAN BROKE THE SHAFT. THE REMAINING COMPONENTS OF THE SHAFT AND BALLOON WERE SUCCESSFULLY RETRIEVED FROM THE PATIENTS BODY USING A SNARE. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21952957 ↗MalfunctionJul 20, 2023Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN LEFT FEMORAL ARTERY. A 4.50 X 32MM SYNERGY XD WAS ADVANCED FOR TREATMENT. HOWEVER, DURING INSERTION INTO THE GUIDE, THE CATHETER WAS BROKEN AND COULD NOT BE DELIVERED. THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17368503 ↗MalfunctionJun 28, 2021Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE CORONARY ARTERY. A 4.50 X 32MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING THE INSERTION, THE SHAFT OF THE DELIVERY SYSTEM BROKE. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12081715 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page